A molecular genetic model of astrocytoma histopathology.
about
In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas.Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro"...those left behind." Biology and oncology of invasive glioma cells.Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients.Identification of prognostic biomarkers for glioblastomas using protein expression profiling.Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.Defective p53 antiangiogenic signaling in glioblastoma.Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.Molecular pathogenesis of pediatric astrocytic tumors.Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labellingPCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activityEvaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation.Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic EventsHistology-based expression profiling yields novel prognostic markers in human glioblastoma.Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization.Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation.Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis.Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).Biologic tumor behavior in pilocytic astrocytomas.Glioblastomas with an oligodendroglial component: a pathological and molecular study.Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model.Molecular genetics of radiographically defined de novo glioblastoma multiforme.Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.Molecular genetic analysis of non-astrocytic gliomas.Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
P2860
Q30444938-828F10A9-42EB-4B62-BF23-4766759E5661Q32001534-4D1C15C0-DB5F-41F6-9848-741224D90052Q33374444-DB56C326-948A-4739-B3E7-B34F90BC4FB1Q33997839-71733279-1730-49C0-B304-C1A42FD9C576Q34102061-B0FEA356-920F-47ED-B413-6985B1C4EF9EQ34104795-A1C5282C-BF19-4BC5-A7B1-52979B3829DBQ34118955-8BB63274-58CC-43CC-85A3-5F6E1823FCF0Q34132978-63F136EA-F933-4A33-A25E-AE546125EC8CQ34133118-CA451591-B7E3-4011-BF1C-910E91C6E1C5Q35570946-F351B8E2-B324-4C22-A7E3-26E8B4734F4FQ35764885-E45EED27-7A62-44FE-9248-2A7F9D06128CQ35799973-DF0ECDC4-D931-4E54-B0C1-818C01053A9BQ36619048-E5295263-50E7-47A5-B5E3-001E11CFF992Q37221647-40937200-880C-4F3E-992E-8F5014EB4282Q37640890-B36C3DAA-248F-42AC-ACDA-E9D5F2AAFFB1Q40706939-C83A52A2-21A7-4275-BC2F-F3F9308448C2Q40835076-DB7CD069-BA9A-4962-BA88-6216162A0E75Q41869473-0E4ACF85-0A71-4791-890D-E62AD1513852Q41896356-66C969D1-975B-431F-8D66-E87AFDDE2107Q43054130-D6433898-6E9E-4370-878C-C63529EDB347Q44117460-AF074822-F4CA-4EA6-A53D-6C83941DF69BQ44603942-BBC61B8E-97F4-45DF-A02E-EA0B6F591D82Q46131414-E8EA02B9-7AAA-41E5-A9AC-D40F8CC904BBQ47294523-839D2FF1-9989-4E80-A9BE-3DDE534BEC81Q48101895-FBC4AE09-E9F8-4BF6-BFB5-DEBC604CBFEAQ48119227-FAF3BDEC-FE0E-447E-83EE-ED45A8E5C8E4Q48144051-E95F63CD-E9C8-47C2-9971-7C2520F0D2D3Q48171207-2172A4A0-DACC-4E97-BD82-C87669A507D2Q48425150-7C29A1E7-8A2D-417F-A94B-886D6E21C3B8Q48712580-EC3EF8E2-82BA-4AA4-8D1D-68A40445CEC9Q48793195-31FB0C6A-EB7B-4D57-98A8-DF8D77205A0EQ48882899-572DCD07-50E6-4CDE-A859-FE6BF3E32515Q49142255-28EBE607-5B15-4F1F-A833-5B9AC37FEE92Q55467284-AC02167A-8FE7-47A9-96CF-BCE67F2EAE53Q55474994-E4E4DAEB-CD91-419A-8EBB-4FE497B7B3E7Q55475569-2E500B59-CA9F-4037-B9CD-DAD0A60EEA3FQ55475713-4DD3B11C-3264-4EB4-A3B5-09CE43CAE1E1Q55475899-55D1DD51-A21A-4E42-9EDF-B33B8573E8B8Q55476987-B1F6338A-2B03-4497-AAFA-B161C14D0B09Q55477117-B7B56781-FCB2-4247-AF2A-13F01450124B
P2860
A molecular genetic model of astrocytoma histopathology.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
A molecular genetic model of astrocytoma histopathology.
@en
type
label
A molecular genetic model of astrocytoma histopathology.
@en
prefLabel
A molecular genetic model of astrocytoma histopathology.
@en
P2860
P1433
P1476
A molecular genetic model of astrocytoma histopathology.
@en
P2093
P2860
P304
P356
10.1111/J.1750-3639.1997.TB01062.X
P577
1997-04-01T00:00:00Z